AGREEMENTAgreement • March 18th, 2016 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Agreement (this “Agreement”) is made and entered into as of March 14, 2016, by and among Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and the entities and natural person listed on Exhibit A hereto and their respective Affiliates (collectively, the “Sub Lender”) (each of the Company and the Sub Lender, a “Party” to this Agreement, and collectively, the “Parties”).
